Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AVITA Medical Inc.

    NASDAQ: RCEL · Real-Time Price · USD
    5.54
    -0.26 (-4.48%)
    At close: Jun 13, 2025, 3:59 PM
    5.50
    -0.72%
    After-hours: Jun 13, 2025, 05:21 PM EDT

    AVITA Medical Statistics

    Share Statistics

    AVITA Medical has 26.43M shares outstanding. The number of shares has increased by 2.16% in one year.

    Shares Outstanding

    n/a
    		 26.43M

    Shares Change (YoY)

    n/a
    		 2.16%

    Shares Change (QoQ)

    n/a
    		 0.53%

    Owned by Institutions (%)

    n/a
    		 25.41%

    Shares Floating

    n/a
    		 26.17M

    Failed to Deliver (FTD) Shares

    n/a
    		 54,819

    FTD / Avg. Volume

    n/a
    		 21.79%

    Short Selling Information

    The latest short interest is 3.96M, so 14.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.96M

    Short % of Shares Out

    n/a
    		 14.98%

    Short % of Float

    n/a
    		 15.1%

    Short Ratio (days to cover)

    n/a
    		 15.28

    Valuation Ratios

    The PE ratio is -5.36 and the forward PE ratio is -8.9. AVITA Medical's PEG ratio is -0.08.

    PE Ratio

    n/a
    		 -5.36

    Forward PE

    n/a
    		 -8.9

    PS Ratio

    n/a
    		 5.16

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 73.64

    P/FCF Ratio

    n/a
    		 -5.69

    PEG Ratio

    n/a
    		 -0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for AVITA Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.83, with a Debt / Equity ratio of 10.22.

    Current Ratio

    n/a
    		 2.83

    Quick Ratio

    n/a
    		 2.47

    Debt / Equity

    n/a
    		 10.22

    Debt / EBITDA

    n/a
    		 -0.83

    Debt / FCF

    n/a
    		 -0.79

    Interest Coverage

    n/a
    		 -10.56

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $247,119.23

    Profits Per Employee

    n/a
    		 $-237,865.38

    Employee Count

    n/a
    		 260

    Asset Turnover

    n/a
    		 0.81

    Inventory Turnover

    n/a
    		 1.25

    Taxes

    Income Tax

    n/a
    		 54K

    Effective Tax Rate

    n/a
    		 -0.09%

    Stock Price Statistics

    The stock price has increased by -32.99% in the last 52 weeks. The beta is 1.55, so AVITA Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.55

    52-Week Price Change

    n/a
    		 -32.99%

    50-Day Moving Average

    n/a
    		 7.71

    200-Day Moving Average

    n/a
    		 9.77

    Relative Strength Index (RSI)

    n/a
    		 35.28

    Average Volume (20 Days)

    n/a
    		 251,579

    Income Statement

    In the last 12 months, AVITA Medical had revenue of 64.25M and earned -61.84M in profits. Earnings per share was -2.39.

    Revenue

    n/a
    		 64.25M

    Gross Profit

    n/a
    		 55.16M

    Operating Income

    n/a
    		 -56.59M

    Net Income

    n/a
    		 -61.84M

    EBITDA

    n/a
    		 -55.34M

    EBIT

    n/a
    		 -56.43M

    Earnings Per Share (EPS)

    n/a
    		 -2.39
    Full Income Statement

    Balance Sheet

    The company has 14.05M in cash and 45.98M in debt, giving a net cash position of -31.93M.

    Cash & Cash Equivalents

    n/a
    		 14.05M

    Total Debt

    n/a
    		 45.98M

    Net Cash

    n/a
    		 -31.93M

    Retained Earnings

    n/a
    		 -359.81M

    Total Assets

    n/a
    		 79.71M

    Working Capital

    n/a
    		 36.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -48.94M and capital expenditures -9.33M, giving a free cash flow of -58.27M.

    Operating Cash Flow

    n/a
    		 -48.94M

    Capital Expenditures

    n/a
    		 -9.33M

    Free Cash Flow

    n/a
    		 -58.27M

    FCF Per Share

    n/a
    		 -2.25
    Full Cash Flow Statement

    Margins

    Gross margin is 85.85%, with operating and profit margins of -88.08% and -96.26%.

    Gross Margin

    n/a
    		 85.85%

    Operating Margin

    n/a
    		 -88.08%

    Pretax Margin

    n/a
    		 -96.17%

    Profit Margin

    n/a
    		 -96.26%

    EBITDA Margin

    n/a
    		 -86.13%

    EBIT Margin

    n/a
    		 -88.08%

    FCF Margin

    n/a
    		 -90.69%

    Dividends & Yields

    RCEL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RCEL is $16.5, which is 184% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $16.5

    Price Target Difference

    n/a
    		 184%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 30, 2020. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Jun 30, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 -6.08

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist